Literature DB >> 28069576

Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.

Francesco Ciccia1, Giuliana Guggino1, Aroldo Rizzo2, Riccardo Alessandro3, Michele Maria Luchetti4, Simon Milling5, Laura Saieva3, Heleen Cypers6,7, Tommaso Stampone2, Paola Di Benedetto8, Armando Gabrielli3, Alessio Fasano9, Dirk Elewaut6,7, Giovanni Triolo1.   

Abstract

BACKGROUND: Dysbiosis has been recently demonstrated in patients with ankylosing spondylitis (AS) but its implications in the modulation of intestinal immune responses have never been studied. The aim of this study was to investigate the role of ileal bacteria in modulating local and systemic immune responses in AS.
METHODS: Ileal biopsies were obtained from 50 HLA-B27+ patients with AS and 20 normal subjects. Silver stain was used to visualise bacteria. Ileal expression of tight and adherens junction proteins was investigated by TaqMan real-time (RT)-PCR and immunohistochemistry. Serum levels of lipopolysaccharide (LPS), LPS-binding protein (LPS-BP), intestinal fatty acid-BP (iFABP) and zonulin were assayed by ELISA. Monocyte immunological functions were studied in in vitro experiments. In addition the effects of antibiotics on tight junctions in human leukocyte antigen (HLA)-B27 transgenic (TG) rats were assessed.
RESULTS: Adherent and invasive bacteria were observed in the gut of patients with AS with the bacterial scores significantly correlated with gut inflammation. Impairment of the gut vascular barrier (GVB) was also present in AS, accompanied by significant upregulation of zonulin, and associated with high serum levels of LPS, LPS-BP, iFABP and zonulin. In in vitro studies zonulin altered endothelial tight junctions while its epithelial release was modulated by isolated AS ileal bacteria. AS circulating monocytes displayed an anergic phenotype partially restored by ex vivo stimulation with LPS+sCD14 and their stimulation with recombinant zonulin induced a clear M2 phenotype. Antibiotics restored tight junction function in HLA-B27 TG rats.
CONCLUSIONS: Bacterial ileitis, increased zonulin expression and damaged intestinal mucosal barrier and GVB, characterises the gut of patients with AS and are associated with increased blood levels of zonulin, and bacterial products. Bacterial products and zonulin influence monocyte behaviour. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Ankylosing Spondylitis; Infections; Inflammation

Mesh:

Substances:

Year:  2017        PMID: 28069576      PMCID: PMC6599509          DOI: 10.1136/annrheumdis-2016-210000

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  76 in total

Review 1.  Revisiting the gut-joint axis: links between gut inflammation and spondyloarthritis.

Authors:  Eric Gracey; Lars Vereecke; Dermot McGovern; Mareike Fröhling; Georg Schett; Silvio Danese; Martine De Vos; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2020-07-13       Impact factor: 20.543

Review 2.  Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects.

Authors:  Siddhartha S Ghosh; Hongliang He; Jing Wang; Todd W Gehr; Shobha Ghosh
Journal:  Tissue Barriers       Date:  2018-02-08

Review 3.  ILC3 in Axial Spondyloarthritis: the Gut Angle.

Authors:  Daniele Mauro; Federica Macaluso; Serena Fasano; Riccardo Alessandro; Francesco Ciccia
Journal:  Curr Rheumatol Rep       Date:  2019-06-13       Impact factor: 4.592

Review 4.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

Review 5.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

Review 6.  Microbiota-mediated mucosal inflammation in arthritis.

Authors:  Meagan E Chriswell; Kristine A Kuhn
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-03-06       Impact factor: 4.098

Review 7.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

Review 8.  The Pathogenesis of Ankylosing Spondylitis: an Update.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2019-11-11       Impact factor: 4.592

Review 9.  Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?

Authors:  Cezmi A Akdis
Journal:  Nat Rev Immunol       Date:  2021-04-12       Impact factor: 53.106

Review 10.  Advances in the role and mechanism of zonulin pathway in kidney diseases.

Authors:  Jie Yu; Ying Shen; Nan Zhou
Journal:  Int Urol Nephrol       Date:  2021-01-11       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.